Shares of Biogen Idec Inc. (Nasdaq: BIIB) rose nearly 5% on Friday after activist investor Carl Icahn received FTC clearance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE